[1]
Oğuzhan Kesen et al. 2019. Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. Turkish Journal of Gastroenterology. 30, 9 (Sep. 2019), 801–806.